Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2013-06-04

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2013-06-04

View Filing

DEFR14A - Revised definitive proxy soliciting materials

Form Type: DEFR14A

Filing Date: 2013-06-04

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2013-05-23

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2013-05-23

View Filing

DEFR14A - Revised definitive proxy soliciting materials

Form Type: DEFR14A

Filing Date: 2013-05-22

View Filing

S-1 - General form for registration of securities under the Securities Act of 1933

Form Type: S-1

Filing Date: 2013-05-15

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2013-05-14

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2013-05-14

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2013-05-08

View Filing